Safety and Efficacy of Bemiparin in the Prevention of Thrombotic Events in Hospitalized Cirrhotic Patients
Status:
Unknown status
Trial end date:
2019-06-01
Target enrollment:
Participant gender:
Summary
Prospectively evaluation of the incidence of thromboembolic events in hospitalized cirrhotic
patients. 2. Efficacy and safety of use of bemiparin in preventing peripheral and portal
thrombosis. 3. Monitoring antiXa levels.